Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers
Clinical trial NCT07437287 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07437287
- Sponsor
- UNICANCER
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2030-04-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.